OMX30 1 516 0,6%  OMXH25 3 665 0,5%  OMXC20 891 -0,2%  Dow 19 778 -0,3%  Nas 5 044 0,0%  EUR 9,5235 0,1%  USD 8,9176 0,3%  Olja 54,2 -2,2%  Guld 1 212 -0,4% 

Johnson & Johnson Aktie

114,71USD -0,14USD -0,12%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Johnson & Johnson

2015 2016e 2017e 2018e 2019e
Utdelning 2,95 3,14 3,33 3,52 3,62
Direktavkastning (i %) 2,87 2,67 2,84 3,00 3,09
PE-tal 16,59 17,49 16,45 15,54 14,71
Resultat/aktie 6,20 6,70 7,13 7,54 7,97
ytterligare nyheter

Analyser om Johnson & Johnson

Jun, 13 2016 Johnson & Johnson Neutral Goldman Sachs Group Inc.
Jan, 27 2016 Johnson & Johnson Hold Independent Research GmbH
Jan, 21 2016 Johnson & Johnson Hold Independent Research GmbH
ytterligare analyser

Johnson & Johnson Peer Group

Abbott Laboratories 40,55
-0,8%
Alexion Pharmaceuticals 135,77
0,4%
AstraZeneca 509,50
0,6%
Bayer 102,00
1,5%
Beiersdorf 81,40
0,1%
Celgene 114,93
0,0%
Fresenius Medical Care 76,23
0,2%
Fresenius 74,42
0,8%
GlaxoSmithKline 15,61
0,6%
Johnson & Johnson 114,71
-0,1%
Merck 61,30
-0,3%
Merck 103,30
1,1%
MorphoSys 49,21
2,5%
Nestle SA 73,75
0,5%
Novartis 72,20
1,2%
Pfizer 32,03
-0,1%
Procter & Gamble 84,98
-0,3%
Roche 238,70
-0,4%
STADA Arzneimittel 48,71
0,9%
Sanofi 76,50
0,5%
Unilever 38,76
0,6%
pagehit

Lägg till instrument

Vad tycker du?

Profil Johnson & Johnson

till bolagsprofilen
Johnson & Johnson operates as an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company, through its subsidiaries operates in three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes a range of products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Realtidskurs Johnson & Johnson

Bid
114,69
USD
Ask
114,70
USD
Kurstid
19:11
Börsen BTT

Aktiekurs Johnson & Johnson i USDPUSH CHART

Kurs 114,71 USD -0,14 -0,12 %
Kurstid 19:11:54
Datum 18.01.2017
Öppning 114,96
Gårdagen 114,85
Dagshögsta 115,09
Dagslägsta 114,43
52 v. högsta 126,25
52 v. lägsta 94,31
52 v. perf.
Volym (Antal) 305 294
Börsvärde (SEK) 2 782,70 Mrd
Börsen
Kurs för 114,71 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 022,94 SEK.

Till aktien Johnson & Johnson

Ticker
ISIN US4781601046
Index S&P 100, NYSE US 100, Dow Jones, S&P 500, BX Swiss - USA

Struktuerarde produkter på Johnson & Johnson

Produkttyp Antal
Plain Vanilla Warrants 1
Certificates 2

Johnson & Johnson Nyckeltal

Börsvärde i SEK 2 782,70 Mrd
Free float % 99,91
Antal aktier mio. 2 720,53
Cashflow/aktie i lokal valuta 6,85
Bokvärde/aktie i lokal valuta 25,84
60 dagar vola 15,88
PBV 3,98

Johnson & Johnson Historiska kurser

2017-01-17 114,85 451 184
2017-01-13 114,60 319 627
2017-01-12 114,62 598 329
2017-01-11 114,68 537 018
2017-01-10 116,19 332 180

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 567,7 %
Ariad Pharmaceuticals Inc. 346,4 %
Exelixis Inc. 342,0 %
Amylin Pharmaceuticals Inc. 264,9 %
Merge Healthcare Inc Cash Settlement At USD 7.13 A Sh 219,3 %